Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gareth R Evans

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2009
Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]D Gareth R Evans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
What Is the Malignancy Risk in Neurofibromatosis Type 1?D Gareth R Evans
Orphanet Journal of Rare Diseases|June 24, 2009
Neurofibromatosis type 2 (NF2): a clinical and molecular reviewD Gareth R Evans
Breast Cancer Research : BCR|September 25, 2007
Breast cancer risk-assessment modelsD Gareth R Evans, Anthony Howell
AME Case Reports|November 7, 2022
Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?D Gareth R Evans, Lauren Lunt
The Application of Clinical Genetics|August 13, 2013
Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumorsD Gareth R Evans, Sarah Louise Ingham
Neuro-Oncology|December 25, 2014
Multifocality in neurofibromatosis type 2D Gareth R Evans, Stavros M Stivaros
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Optimal selection of individuals for BRCA mutation testingD Gareth R Evans, Fiona Lalloo, Diana Eccles
Clinical Genetics|February 10, 2023
Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosisDorothy Halliday, Beatrice Emmanouil, D Gareth R Evans
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-LetterD Gareth R Evans, Elaine Harkness, Fiona Lalloo
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2009
Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]D Gareth R Evans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
What Is the Malignancy Risk in Neurofibromatosis Type 1?D Gareth R Evans
Orphanet Journal of Rare Diseases|June 24, 2009
Neurofibromatosis type 2 (NF2): a clinical and molecular reviewD Gareth R Evans
Breast Cancer Research : BCR|September 25, 2007
Breast cancer risk-assessment modelsD Gareth R Evans, Anthony Howell
AME Case Reports|November 7, 2022
Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?D Gareth R Evans, Lauren Lunt
The Application of Clinical Genetics|August 13, 2013
Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumorsD Gareth R Evans, Sarah Louise Ingham
Neuro-Oncology|December 25, 2014
Multifocality in neurofibromatosis type 2D Gareth R Evans, Stavros M Stivaros
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Optimal selection of individuals for BRCA mutation testingD Gareth R Evans, Fiona Lalloo, Diana Eccles
Clinical Genetics|February 10, 2023
Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosisDorothy Halliday, Beatrice Emmanouil, D Gareth R Evans
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-LetterD Gareth R Evans, Elaine Harkness, Fiona Lalloo
Pageof 11